Optical Coherence Tomography Findings in Diabetic Macular Edema by Desislava Koleva-Georgieva
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Optical Coherence Tomography 
 Findings in Diabetic Macular Edema 
Desislava Koleva-Georgieva 
University Eye Clinic, University Hospital”St. George”, Plovdiv 
Bulgaria 
1. Introduction 
Diabetic macular edema (DME) is one of the main causes of visual impairment in patients 
with diabetic retinopathy (Williams et al., 2004). The common diagnostic tools for assessing 
macular edema are stereo-ophthalmoscopy and fluorescein angiography. Stereoscopic 
examination of the fundus at the slit-lamp or on stereoscopic color fundus photographs is 
the standard method, as defined by the Early Treatment Diabetic Retinopathy Study 
(ETDRS), for evaluating macular thickening and for starting treatment when the clinical 
significant macular edema level has been reached (ETDRS Report Number 10, 1991). 
Fluorescein angiography is a complementary method for further detecting vascular leakage. 
However, these methods are subjective and seem to be insensitive for small changes in 
retinal thickness (Hee et al., 1995; Shahidi et al., 1991). In 1991 a revolutionary device was 
introduced in ophthalmology – optical coherence tomography (OCT) – and it dramatically 
improved the diagnosis of macular pathology (Huang et al., 1991). OCT provides detailed 
information about retinal microstructure and measures retinal thickness with high precision 
and reproducibility (Diabetic Retinopathy Clinical Research Network [DRCRN], 2007; 
Paunescu et al., 2004; Polito et al., 2005; Puliafito et al., 1995). The recently introduced 
spectral-domain OCT (SD OCT) machines have numerous improvements that enhance our 
ability to examine retinal microstructure and obtain more reliable measurements. 
2. OCT principles and interpretation 
2.1 OCT principles 
OCT is a modern imaging technique for non-invasive and non-contact “in vivo” 
examination of the retina and the vitreoretinal interface on cross-section images or on a 3D 
image reconstruction, and for objective measurement of retinal thickness (Hee et al., 1995; 
Huang et al., 1991; Schuman et al., 2004). Its high resolution (5-10μm) is unobtainable for 
any other device. The operating principle resembles echography, but instead of ultrasound a 
low-coherent light signal is used. The first OCT devices are referred to as time-domain OCT 
(TD OCT). TD OCT technology relies on an optical technique known as Michelson low 
coherence interferometry (Shuman et al., 2004). The image acquisition and thickness 
measurements are achieved by detecting the echo time delay of the backreflected or 
backscattred light from internal retinal structures while it interferes with the light that has 
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traveled a known path length. This is obtained by moving a reference mirror and the signal 
collection is a function of time (Brancato & Lumbroso, 2004; Schumann et al., 2004).  
In the past few years SD OCT technology was introduced. At present there are two 
techniques for SD OCT. The first uses a spectrometer for detecting and measuring the light 
spectrum returning from tissue and a stationary reference mirror. Here mathematical 
operations, called Fourier transforms, are used. Thus SD OCT is also referred to as Fourier-
domain OCT. As this technology allows detecting all echoes of backreflected light 
simultaneously and there are no moving parts, the imaging speed and resolution of SD OCT 
are higher than those of TD OCT (Podoleanu, 2005; van Velthoven et al., 2007). The second 
SD OCT technique is called “swept source-OCT”. It uses a light source in which the 
emission wavelength is tuned rapidly over a broad wavelength range (Choma et al., 2003; 
Podoleanu, 2005). The main advantages of SD OCT over TD OCT are the increased imaging 
speed, the higher resolution and sensitivity, the possibility of obtaining a 3D retinal image 
reconstruction, more reliable thickness measurements and topographic retinal analyses.  
2.2 OCT interpretation 
The interpretation of OCT is based on analysis of various qualitative and quantitative data 
(Brancato & Lumbroso, 2004; Schuman et al., 2004). Before performing these analyses, an 
assessment of the OCT scan quality has to be made and the presence of scan artifacts has to be 
detected, since they can lead to retinal thickness measurement errors and false conclusions. 
The artifacts may be operator-induced (defocusing, depolarization and out of range image), 
patient-induced (off-center fixation resulting in incorrectly centered retinal thickness maps, 
blink and motion artifacts) or may be due to the limitations of the imaging technique (TD OCT 
has lower imaging speed and frequent blink and motion artifacts). All these artifacts have been 
recognized to cause breakdown in the performance of the segmentation software and thus 
leading to incorrect automated retinal thickness measurements (Ho et al., 2009; Ray et al., 2005; 
Sadda et al., 2006). Several studies have pointed out that segmentation breakdown may also be 
possible in high quality scans if there are pathological features such as full-thickness macular 
hole, pigment epithelial detachment, subretinal fluid, retinal fibrosis and hard exudates 
(Domalpally et al., 2009; Ho et al., 2009; Krebs et al., 2009; Sadda et al., 2006). The presence of 
media opacities (cataract, vitreous hemorrhage, ect.) and low signal intensity (low signal-to-
noise ratio) may also induce segmentation breakdown. Although much progress has been 
made in improving the accuracy of the segmentation software, and the SD OCT devices 
perform better than the TD OCT, segmentation breakdown still occurs with the current SD 
OCT software. There is possibility of manual correction, but still it is time consuming and not 
always feasible in clinical settings. At this point it seems prudent to note this limitation of the 
current OCT software. Thus, until improvement in the segmentation algorithm is available, the 
clinician may minimize possible diagnostic and therapeutic errors when working with the 
current OCT devices by anticipating and recognizing automated retinal thickness 
measurement errors. 
2.2.1 OCT characteristics of normal macular morphology 
The interpretation of qualitative data is based on analyzing tissue reflectivity. As OCT has 
histological correspondence (Toth et al., 1997), the interpretation of the OCT image seems to 
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be quite intuitive.  However, it should be always remembered that OCT technology depicts 
tissue reflectivity. It is dependent on tissue optical properties, i.e. microscopic variations in 
the refractive index of subcellular structures, and on the amount of light signal absorbed by 
the overlying tissues (Brancato & Lumbroso, 2004; Schumann et al., 2004). Normal macular 
histology is divided into 10 distinct layers: inner limiting membrane (ILM), nerve fiber layer 
(NFL), ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), 
outer plexiform layer (OPL), outer nuclear layer (ONL), external limiting membrane (ELM), 
rod and cone layer, and retinal pigment epithelium layer (RPE), (fig.1). They are formed by 4 
cell types: RPE, photoreceptors, bipolar and ganglion cells. The reflectivity of the various 
layers is represented in the OCT scans by the so called false colors (a color coded way – 
white and red for high reflectivity, and blue and black for low reflectivity). The ILM is the 
first detected layer on the OCT scan, due to the contrast between the non-reflective vitreous 
and the reflective retina. Immediately behind it lies the NFL. It consists of horizontal axonal 
structures of high optical reflectivity and is depicted on OCT scans by red color. The NFL is 
thicker on the nasal side, because of the density of the papillomacular bundle. The plexiform 
layers are of medium reflectivity and appear yellow on the scans. The nuclear layers (GCL, 
INL and ONL) are of low optical reflectivity and appear as blue-black. The GCL is thickest 
in the parafoveal area. In the fovea there is thinning of the retina with absence of the inner 
layers and an increase in thickness of the ONL. It is easily recognized on the scans by its 
characteristic depression. The RPE, which contains melanin, is highly reflective and is the 
outermost red layer on the OCT scan. Behind it is the medium reflective choriocapillaris. 
 
Fig. 1. Normal macular structure – SD OCT representation of retinal layers: inner limiting 
membrane (ILM), nerve fiber layer (NFL), ganglion cell layer (GCL), inner plexiform layer 
(IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), 
external limiting membrane (ELM), inner segments (IS) and outer segments (OS) of the 
photoreceptors, IS/OS junction (IS/OS), and the retinal pigment epithelium layer (RPE). 
In front of the RPE on Stratus TD OCT scans and on SD OCT scans there is another highly 
reflective (red) layer – it is the boundary between the inner segments (IS) and the outer 
segments (OS) of the photoreceptors. On TD OCT two highly reflective lines in the outer 
retina are visualized (as described above). On SD OCT there are three highly reflective lines 
in the outer retina – the innermost being the IS/OS junction, the outermost being the RPE, 
and the middle one is described to be the outermost tips of the OS, containing discs, rich in 
rhodopsin (Ooto et al., 2010; Srinivasan et al., 2006). On SD OCT despite these three highly 
reflective layers, a forth thinner high-to-medium reflective line is also visible in front of the 
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IS/OS layer and it represents the ELM. If an OCT scan intersects a retinal blood vessel it can 
be identified by the increased reflectivity and shadowing of the deeper structures. 
2.2.2 OCT interpretation – qualitative analysis (morphology and reflectivity) 
While performing qualitative analysis one should simultaneously perform morphological 
examination (changes in retinal profile – surface and posterior layers, and presence of 
abnormal structures) and reflectivity examination (hyper-reflectivity, hypo-reflectivity, and 
shadowing effects) (Brancato & Lumbroso, 2004). Pathological changes in retinal surface 
contour may represent disappearance of the normal foveal depression (in macular edema). 
Steepening of the foveal contour may be associated with epiretinal membranes, macular 
pseudoholes or lamellar holes. OCT can distinguish between lamellar holes, pseudoholes or 
various stages of full thickness macular holes. Pathological changes in posterior layers may 
be RPE detachments (form steep angles with the choriocapillaris) and neurosensory retinal 
detachments (form shallow angles with the RPE and protrude less). Retinal drusen produce 
wavy undulations of the pigment epithelium line. Abnormal intraretinal structures may be 
cotton wool spots (superficial hyper-reflective nodules with indistinct margins in the NFL), 
hard exudates (round numerous or plaque-like hyper-reflective spots usually in the inner 
layers, shadowing the deeper structures), choroidal neovascular membranes (nodular or 
rounded fusiform hyper-reflective structures in front of the RPE, or sometimes visualized as 
localized thickening of the RPE, choriocapillaris and OS, usually associated with edema or 
serous retinal detachment), fibrous scars (hyper-reflective structures in the outer retina that 
deform reduced in thickness retinal layers).  
Retinal pathological features can be associated with changes in optical properties of the 
tissue and thus be detected on the OCT scan as changes in reflectivity. While performing 
this reflectivity analysis one should always remember that the reflectivity displayed on the 
scan is a result from the tissue reflectivity, the amount of light absorbed by overlying 
structures, and the amount of light that reaches the sensor after it has been further 
attenuated by interposing tissues. Thus care is required in interpreting OCT images when 
media opacities, poor alignment of the OCT instrument while imaging, high astigmatism or 
poorly centered intraocular implants are present, as these may reduce signal intensity. 
Pathological features that can be hyper-reflective are: epiretinal and thick vitreal 
membranes, cotton wool spots, hard exudates, thick hemorrhages, retinal fibrosis, RPE 
hyperplasia or pigmented choroidal nevi, neovascular membranes, atrophy of the retina and 
RPE (the later cause increased reflectivity of the underlying choroid). Reduced reflectivity 
(hypo-reflectivity) is most often caused by fluid accumulation: intraretinal edema (it may be 
associated with formation of optically non-reflective cystoid spaces), or subretinal edema 
(serous neuroepithelial retinal detachment, serous pigment epithelial detachment). Hypo-
reflectivity may also be present in retinal and RPE atrophy or RPE hypopigmentation, 
where along with tissue hypo-reflectivity there is increase of the reflectivity of the 
underlying choroid. 
2.2.3 OCT interpretation – quantitative analysis 
The quantitative analysis is a very important part of OCT interpretation. Quantitative 
measurements of retinal thickness, volume, and a variety of structures (i.e. retinal 
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morphometry) provide objective information for diagnosing disease, tracking disease 
progress, and evaluating response to therapy. The availability of highly reproducible and 
repeatable retinal thickness measurements (DRCRN, 2007; Paunescu et al., 2004; Puliafito et 
al., 1995) is prerequisite for early diagnosis of macular edema. 
Retinal thickness and volume are automatically calculated by the computer software and are 
displayed in numerical values (table format) or in color coded topographic retinal thickness 
maps. Retinal thickness is calculated for central fixation point, 9 ETDRS-like macular regions 
and total macular thickness. Retinal volume is displayed for 9 ETDRS-like macular regions 
and total macular volume (not all OCT devices display volume). The 9 ETDRS-like macular 
regions consist of one central circle of 500 μm radius (the foveal region), an inner and outer 
ring, each divided into four quadrants. The topographic color coded retinal thickness map 
(white and red for high thickness values, and blue for low thickness values) provides more 
graphic information that can be compared directly to the fundus image. 
The automatic calculation of retinal thickness is dependent on a computer image-processing 
algorithm called segmentation. It allows automatic detection of the inner and outer retinal 
boundaries. After that automatic calculation of the measurements between these boundaries 
is performed (Schuman et al., 2004). At this point several important notes have to be made. 
First, in TD OCT the retinal thickness topographic map is displayed after interpolation of 
the measured retinal thickness form 6 radial cross-section scans (overall 6x512=3072 A-
scans, or 6x128=768 A-scans for the entire macular area). The interpolation may miss 
pathologic areas with increased/decreased thickness between the 6 radial lines. In SD OCT 
retinal thickness topographic map is displayed after performing measurements from a great 
number of A-scans (27 000 A-scans for Cirrus HD-OCT (Carl Zeiss Meditec) and Spectral 
OCT/SLO (OPKO/OTI), 40 000 A-scans for Spectralis (Heidelberg Engineering), and over 
50 000 A-scans for high resolution OCT devices). Thus retinal thickness measurement with 
SD OCT provides more precise and reliable data. Second, the different OCT devices have 
different segmentation algorithms, and there is published evidence of significant differences 
between TD OCT and SD OCT, as well as between different SD OCT machines (Han et al., 
2009; Leung et al., 2008; Wolf-Schnurrbusch et al., 2009). The difference is mainly caused by 
the way of delineating the outer retinal boundary (at the level of the first, second or third 
hyper-reflective line in the outer retina). Thus measurements from different OCT devices 
cannot be compared in studies, as well as in the follow-up of patients in clinical settings. 
Third, the segmentation algorithm may not perform correctly in the presence of scan 
artifacts or particular pathological features and lead to thickness measurement errors (as 
described in 2.2.OCT interpretation). 
The data base for normal retinal thickness should be different for the different OCT devices. 
There are a lot of studies on retinal thickness measurements in healthy eyes, and their 
number is even increasing with the introduction of new OCT machines. Normal values for 
the central point and foveal thickness according to several studies, using TD OCT and SD 
OCT are presented on table 1. The diversity of data for normal eyes seems to be much more 
confusing, than helpful. There is a general trend of measuring higher values of retinal 
thickness with more refined OCT technology. All measurements with SD OCT have higher 
values than measurements with TD OCT. The greater axial resolution of SD OCT (5-6 μm) 
compared to TD OCT (10 μm) and the higher precision of the software may explain the 
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difference between TD OCT and SD OCT. The differences among the several types of SD 
OCT devices may also be significant and are due to the segmentation of the outer retinal 
boundary. The presented data on table 1 also suggest differences even in measurements 
with identical OCT devices. This may be due to the specific characteristics and composition 





OCT device CFP Fovea 
Hee et al., 1995  20 Time-domain OCT prototype 147 ± 17 - 
Hee et al., 1998 73 Time-domain OCT prototype 152 ± 21 174 ± 18 
Otani et al., 1999  10 Time-domain OCT 1 133 ± 9 - 
Schaudig et al., 2000  25 Time-domain OCT 1 152 ± 17 - 
Massin et al., 2002 60 Time-domain OCT 1 146 ± 20 170 ± 18 
Paunescu et al., 2004 10 Time-domain OCT 3 (Stratus) 164 ± 21 204 ± 20 
Chan A et al., 2006 37 Taim-domain OCT 3 (Stratus) 182 ± 23 212 ± 20 
Bressler et al., 2008 97 Time-domain OCT 3 (Stratus) 166 ± 23 201 ± 22 
Kelty PJ et al., 2008 83 Time-domain OCT 3 (Stratus) - 205 ± 27 
El-Ashry et al., 2008 200 Time-domain OCT 3 (Stratus) 173 ± 23 203 ± 24 
Leung CK et al., 2008 35 Time-domain OCT 3 (Stratus) 
Spectral OCT - Topcon 3D OCT 
155 ± 16 
- 
196 ± 17 
216 ± 12 
Huang et al., 2009 32 Time-domain OCT 3 (Stratus) 
Spectral OCT – RTVue-100 
164 ± 26 
175 ± 17 
193 ± 22 
208 ± 21 
Wolf-Schnurrbusch UEK 
et al., 2009 














213 ± 19 
 
288 ± 16 
243 ± 25 
276 ± 17 
246 ±23 
245 ± 28 
Koleva-Georgieva et al, 
2010 
39 Spectral OCT/SLO 176 ± 17 198 ± 21 
Grover S et al., 2010 36 Time-domain OCT 3 (Stratus) 
Spectral OCT - Spectralis OCT 
167 ± 21 
225 ± 17 
202 ± 23 
271 ± 20 
Ooto S et al., 2010 248 Spectral OCT – 3-D OCT-1000 - 222 ± 19 
Table 1. Normal retinal thickness measurements for central fixation point (CFP) and fovea, 
represented in μm (mean ± standard deviation), obtained by different OCT devices. 
There is not a commonly accepted opinion about the variation of retinal thickness with age. 
Several authors have reported a lack of relation between retinal thickness and age 
(Browning et al., 2008; Chan et al., 2006; Grover et al., 2010; Hee et al., 1995; Massin et al., 
2002; Sanchez-Tochino et al., 2002). Others have found negative correlation between retinal 
thickness and age in all 9 ETDRS regions (Alamouti & Funk, 2003; Erikson & Alm, 2009), 
and in five of the 9 ETDRS areas not including the fovea (Ooto et al., 2010). There is a well 
known decrease in thickness of the NFL with age. According to Erikson and Alm the 
thinning of the macula with age is 20-25% due to thinning of NFL and 75-80%due to 
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thinning of other retinal layers (Erikson & Alm, 2009). Thus the reduction of retinal 
thickness with age cannot be contributed to thinning of NFL alone.  
It has been reported that men have thicker retinas than women (Browning et al., 2008; 
Guedes et al., 2003; Hee et al., 1995; Kelty et al., 2008; Massin et al., 2002; Ooto et al., 2010). 
However, Chan and coauthors and Grover and coauthors did not detect significant inter-sex 
difference in retinal thickness, but their studied groups had uneven sex distribution (Chan et 
al., 2006; Grover et al., 2010).  
There is published evidence of racial differences in retinal thickness. It has been reported 
that Blacks and Asians have thinner retinas compared with whites in age-matched groups 
(Asenfzadeh et al., 2007; Guedes et al., 2003; Kelty et al., 2008). Thus, race may be taken into 
consideration while interpreting OCT thickness measurements. 
The relation of macular thickness to axial length and presence of high myopia has also been 
described. Retinal thickness in highly myopic eyes (>6D) was higher in the fovea, but lower 
in the inner and outer regions compared to non-myopic eyes in a study with age-matched 
groups (Wu et al., 2008). Thus it may be an indication for change in retinal contour of highly 
myopic eyes and care is needed while interpreting macular pathology on OCT scans of such 
eyes. The studies of Lam and coauthors and Lim and coauthors showed negative correlation 
of retinal thickness and axial length (Lam et al., 2007; Lim et al., 2005). However, both 
studies included highly myopic eyes together with non-myopic eyes, and did not perform 
age-adjusted analysis. In their investigation on 248 eyes, Ooto and associates found no 
correlation between macular thickness and age-adjusted axial length (Ooto et al, 2010).  
We performed a study including 39 healthy eyes, with almost even sex distribution (21 men; 
18 women), accepting refractive error of no more than ± 3D, without glaucoma and all 
subjects being of Caucasian descent (Koleva-Georgieva & Sivkova, 2010). The automated 
retinal thickness and volume measurements were obtained by Spectral OCT/SLO 
Combination Imaging System (OPKO/OTI). A negative correlation between age and retinal 
thickness and volume in all ETDRS regions, except the temporal inner and temporal outer 
regions was found, and this relation remained after controlling for gender. Men had thicker 
retinas than women, and this remained so after controlling for age. These results are in 
consent with some authors and in discrepancy with others. One reason may be the small 
sample size in many of the studies, or the heterogeneity of retinal thickness in different 
populations. Additional studies with larger sample sizes are needed to clarify the situation. 
If quantitative analysis should be meticulous the normative database for retinal thickness 
probably should be population-based and obtained for each OCT machine type separately. 
Still our findings, supported by others, indicate that age, sex, and high myopia must be 
considered while interpreting retinal thickness data.  
3. OCT findings in DME 
3.1 Retinal thickness 
Retinal edema is defined as any detectable retinal thickening due to fluid accumulation 
(ETDRS Report Number 10, 1991). Stereoscopic examination of the fundus is the standard 
method, as defined by the ETDRS, for evaluating macular thickening. However, it is 
subjective and seems to be insensitive for small changes in retinal thickness (Hee et al, 1995; 
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Shahidi et al, 1991). The particular value of OCT is the possibility for objective, reliable and 
repeatable retinal thickness measurements. Since the introduction of OCT several authors 
have studied the possibility of OCT for early diagnosis of macular edema, and have 
suggested criteria to detect the so called subclinical diabetic macular edema (Hee et al., 1995, 
1998; Massin et al., 2002). There are studies reporting significant differences in retinal 
thickness between controls and eyes with diabetic retinopathy (without clinically detectable 
DME) in the fovea (Sanchez-Tochino et al., 2002; Schaudig et al., 2000), superior and nasal 
quadrants (Schaudig et al., 2000). Difference was also found between healthy eyes and 
diabetics without diabetic retinopathy in the fovea (Sanchez-Tochino et al., 2002), the 
paramacular ring (Schaudig et al., 2000) and the superior zone (Sugimoto et al., 2005). When 
comparing eyes of diabetics with and without retinopathy (and no clinical evidence of 
macular edema) Sanchez-Tochino and coauthors did not find any significant difference 
(Sanchez-Tochino et al., 2002), but Schaudig and associates found statistically significant 
difference in the superior nasal quadrant (Schaudig et al., 2000). 
In a clinical study we compared retinal thickness between diabetic patients without clinical 
evidence of DME (1st group – 57 eyes of 29 patients without diabetic retinopathy; 2nd group 
– 63 eyes of 32 patients with diabetic retinopathy) and a control group (39 healthy eyes), 
(Koleva-Georgieva & Sivkova, 2010).  All groups were age-matched and with nearly even 
sex distribution. The tendency of men having thicker retinas than women, and decrease of 
thickness with age were noted also for diabetic patients from both groups, although not 
reaching significance for all macular areas. We found significant differences in retinal 
thickness between controls and diabetics with diabetic retinopathy (group 2) in all macular 
regions, and also between controls and diabetics without retinopathy (group 1) in all regions 
except superior inner, inferior inner and nasal inner. It was present also after controlling for 
age and gender. The differences were present in more macular regions than detected by 
other authors. It might be due to the greater resolution and precision of the SD OCT that we 
used. So, OCT could detect early and subtle increase in retinal thickness in eyes with or even 
without retinopathy in comparison to healthy eyes. When comparing eyes of diabetics 
without retinopathy (group1) to those with diabetic retinopathy (group 2) we found 
significant difference in the central fixation point, fovea, superior inner, temporal inner, 
nasal inner regions and total retinal thickness. This indicated that SD OCT could further 
distinguish early macular damage in eyes with diabetic retinopathy compared to eyes 
without retinopathy. These early changes were more likely to develop in the central region 
and superior macular hemisphere (Koleva-Georgieva & Sivkova, 2010; Schaudig et al., 2000; 
Sugimoto et al., 2005). This evidence, published by many authors, suggests the possibility of 
OCT for the early detection of macular edema in diabetic patients. 
If we need to know whether a given diabetic patient has early macular damage, detectable 
by OCT, we have to apply some criteria. Ever since the pioneers of OCT have examined this 
possibility they have given several criteria: retinal thickness exceeding mean+3SDs 
(standard deviations) from normal subjects (Hee et al., 1995), retinal thickness exceeding the 
maximal thickness in normal eyes, difference between the right and left eyes exceeding 
mean difference in healthy eyes+2SDs, comparison with the database from normal 
population, and comparison with previous measurements (Hee et al., 1995, 1998). Hee and 
associates found 3 eyes (from 55 eyes) of diabetics without retinopathy with evidence of 
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early damage according to their criterion on difference between right and left eyes (Hee et 
al., 1998).  Massin and coauthors suggested early macular edema to be present if retinal 
thickness of an area was greater than the mean +2SDs in the corresponding area of normal 
subjects (Massin et al., 2002). This will exceed the variation in 95% of the normal population. 
They detected early macular thickening in 12 eyes (from 70 eyes) of diabetic patients 
without edema on ophthalmoscopy. In our study we did not apply the criterion of 
difference between right and left eyes, because Spectral OCT/SLO does not give this 
information automatically as Stratus TD OCT does. We applied the criterion of retinal 
thickness exceeding mean+2SDs from normal values for both the central fixation point and 
the fovea (both being in the clinically significant zone) to distinguish eyes with early 
subclinical DME (Koleva-Georgieva & Sivkova, 2010). Thirteen eyes were detected with 
retinal thickness exceeding both 209.6 µm for the central fixation point (176 µm+2x16.8 µm) 
and 241.1 µm for the fovea (198.3 µm +2x21.4 µm). All 13 eyes had retinopathy – 12 eyes 
with mild non-proliferative diabetic retinopathy and 1 eye with moderate non-proliferative 
diabetic retinopathy. In contrast to the finding of Browning and coauthors that only eyes 
with late stages of retinopathy (severe non-proliferative or proliferative) with no clinically 
detectable edema had thicker retinas than healthy eyes (Browning et al, 2008), we detected 
early subclinical macular damage also in eyes with mild and moderate non-proliferative 
diabetic retinopathy. That’s why we believe that OCT examination could be useful in 
patients with any severity of diabetic retinopathy, even in the earliest stages, and this would 
be at least for two reasons: first – to screen for early DME and eventually consider a closer 
follow-up, and second – to have a baseline measurement of retinal thickness for future 
comparison. This evidence confirms that SD OCT can possibly detect early subclinical 
macular edema in eyes with diabetic retinopathy. In the clinical setting, it is not advisable to 
use the above reported values of normal retinal thickness due to differences in population 
characteristics. However, the preset criteria defining early macular damage may be used, 
and attention should be paid to age, gender, ethnicity and presence of high myopia.  
OCT is also a valuable method for quantifying treatment effects after laser 
photocoagulation, vitrectomy, or intravitreal application of steroid and anti-VEGF 
injections. The assessment of the effect of each treatment has to be judged both by the 
improvement of visual acuity and by the observation of structural changes induced. OCT 
has proved to be beyond comparison for the latter, and has the value of objectively 
quantifying even subtle changes in retinal thickness. The high reproducibility of retinal 
thickness measurements allows OCT to be used for longitudinal objective monitoring of the 
treatment efficacy. A change in macular thickness of more than 10% of the baseline 
measurement has been considered as significant and not due to the variability of the method 
(Massin et al., 2001; Polito et al., 2005). It is worth noting here that fluorescein angiography 
also has its value in verifying macular ischemia. Several studies have stated that macular 
ischemia is a possible explanation for the lack of functional improvement in patients with 
good structural outcome after conservative or surgical treatment (Massin et al., 2003; Otani 
& Kishi, 2000). However, OCT is becoming the mainstay of objective treatment monitoring 
and follow-up of patients with macular edema. It is widely accepted in trials and studies 
(DRCRN, 2010; Estabrook et al., 2007; Otani & Kishi, 2000; Ozdemir et al., 2005; Patel et al., 
2006), as well as in clinical settings. 
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3.2 Retinal microstructure 
The main characteristic OCT features of macular edema are: increased retinal thickness, 
reduced intraretinal reflectivity, irregularity of the layered structure, and flattening of the 
foveal depression (fig. 2). If edema persists, cystoid cavities may appear (Brancato & 
Lumbroso, 2004; Saxena & Meredith, 2006; Schumann et al., 2004). In macular edema serous 
fluid may be present under a detached neurosensory retina as a serous macular detachment 
(SMD). Hard exudates, hemorrhages and cotton-wool spots may also be present in macular 
tissue and their characteristics have been described (2.2.2.OCT interpretation – qualitative 
analysis).  
 
Fig. 2. Simple non-cystoid diabetic macular edema: increased retinal thickness, flattening of 
the foveal depression, irregularity of the layered structure, hard exudates (multiple red 
spots with shadowing of underlying tissue), without cystoid spaces. 
The accumulation of intraretinal fluid leads to increase in retinal thickness and reduction of 
optical reflectivity. The layered macular structure becomes irregular. In our studies (Koleva-
Georgieva & Sivkova, 2008; 2009), and also in others (Kim et al., 2006; Otani et al, 1999) it 
was described that areas with reduced reflectivity were located mainly in the outer retinal 
layers and the inner layers were displaced anteriorly. This was noted especially for simple 
macular edema, which is the beginning of retinal disruption. According to histopathologic 
studies of eyes with macular edema, fluid accumulation starts with intracytoplasmic 
swelling of Müller cells in the outer plexiform layer of Henle (Yanoff et al., 1984). Areas with 
reduced reflectivity on OCT images probably represent the swollen Müller cells. If macular 
edema persists, necrosis of Müller cells and the adjacent neurons occurs (Yanoff et al., 1984). 
This leads to cystoid cavity formation in the retina.  
 
Fig. 3. Mild cystoid diabetic macular edema: intraretinal cystoid spaces with horizontal 
diameter < 300μm. 
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Fig. 4. Intermediate cystoid diabetic macular edema: intraretinal cystoid spaces with 
horizontal diameter ≥ 300μm < 600μm (star), note smaller cystoid spaces located in the inner 
layers (white arrowheads), epiretinal membrane with focal adhesions and distortion of 
retinal contour (white arrow), and posterior hyaloid detached from retinal surface (yellow 
arrows) with peripapillary adhesion (not shown on this scan). 
 
Fig. 5. Severe cystoid diabetic macular edema: intraretinal cystoid spaces with horizontal 
diameter ≥ 600μm (star), note smaller cystoid spaces located in the inner layers (white 
arrowheads). 
On OCT images cystoid cavities appear as black non-reflective spaces, surrounded by 
medium-to-low reflective septa (fig. 3, 4 and 5). On en face OCT images cystoid spaces have 
well defined septae and, since this scan lies in the coronal plane, we may draw out 
additional information about the extent and location of the cystoid spaces. The cystoid 
cavities were observed to be located in the outer layers in newly developed edema, and to 
engage the inner layers in well-established edema forming large confluent cystoid cavities 
(Otani et al., 1999). In our study we found correlation between the size of cystoid spaces and 
retinal thickness and visual acuity (Koleva-Georgieva & Sivkova, 2008). We decided to 
subdivide cystoid DME into mild, moderate, and severe according to the size of cystoid 
spaces (fig. 3, 4 and 5). The mild cystoid DME presents with small cysts mainly in the outer 
retinal layers. The cystoid spaces in eyes with intermediate and severe cystoid DME were 
mainly located in the outer layers, predominantly in the fovea. Still, some of these eyes also 
had small cysts in the inner layers. We assume that fluid accumulation in cystoid spaces in 
the inner retinal layers could be a result of the progression of macular edema. With 
progression, disruption of cystic septae may ensue. Large confluent cystoid cavities may 
form to involve almost the entire thickness of the retina and give a retinoschisis appearance. 
In these cases a thin layer of atrophic retinal tissue remains over the retinoschisis spaces, and 
the eyes have profound visual loss. This probably represents the last stage of retinal 
disruption. The lower visual acuity in eyes with severe cystoid DME and the statistically 
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significant difference when comparing with the milder cystoid DME types show that the 
subtypes of cystoid DME could be consecutive stages of macular edema progression with 
worsening of visual function. We recommend that the size of cystoid spaces should be 
analyzed when evaluating patients with DME.  
 
Fig. 6. Serous macular detachment: a dome-shaped hypo-reflective area under the detached 
neurosensory retina and over the hyper-reflective layer of the pigment epithelium (white 
arrow), note the association with severe cystoid space (white star), confluent cystoid spaces 
with retinoschisis appearance (yellow stars), and the small cystoid spaces in the inner layers 
(arrowheads). 
 
Fig. 7. 3D OCT image reconstruction with consequent coronal and longitudinal slicing: 
represents serous macular detachment (black arrow) and cystoid spaces (black arrowhead), 
note that the reflectivity of the serous macular detachment border (representing 
photoreceptor IS/OS) is more reflective than the cystoid septae. 
In eyes with macular edema the pattern of SMD may also be found (Alkuraya et al., 2005; 
Catier et al., 2005; Kaiser et al., 2001; Kim et al., 2006; Koleva-Georgieva & Sivkova, 2009; 
Otani et al., 1999; Panozzo et al. 2004). This feature can be detected “in vivo” only by means 
of OCT, as it does not show on ophthalmoscopy or fluorescein angiography. However, it 
has been well documented by Wolter in a histopathology study on eyes with DME (Wolter, 
1981). The pathogenesis of SMD is not completely understood, and its significance still 
remains unknown. The most debatable factor is macular traction. Some authors point out 
traction as a leading cause (Kaiser et al., 2001), while others completely reject this hypothesis 
(Catier et al., 2005). There are statements that SMD is innocuous and transient (Ozdemir et 
al., 2005), while others state it is the last stage of chronic edema (Brancato & Lumbroso, 
2004). 
On OCT scans SMD appears as a low-reflective area under the detached neurosensory retina 
and over the hyper-reflective line of the pigment epithelium. It is usually confined to the 
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foveal area (fig. 6). On en face OCT scans SMD appears as round area of low reflectivity, 
surrounded by a medium reflectivity line (fig. 7). In our study on 79 eyes with DME, we 
found SMD in 9 eyes (11.4%), (Koleva-Georgieva & Sivkova, 2009). This prevalence is 
comparable to other studies (Alkuraya et al., 2005; Kang et al., 2004; Kim et al., 2006; Otani et 
al., 1999).  In our cohort of studied eyes, SMD was combined predominantly with cystoid 
edema pattern (intermediate cystoid in 5 eyes, severe cystoid in 3 eyes), and was combined 
with simple edema pattern only in 1 eye. The cystoid spaces were located in the outer retinal 
layers and the largest ones leaned to the center of fovea. In 6 eyes we also observed smaller 
cystoid spaces in the inner retinal layers that tended to be outside the fovea. Hard exudates 
were seen in 5 eyes. On fluorescein angiography the eyes with SMD presented with diffuse 
leakage in one eye and cystoid edema pattern in 8 eyes. Macular ischemia was found in 6 
eyes. There was similarity in the distribution of macular traction types among eyes with 
SMD (no traction – 3 eyes, questionable – 3 eyes, and definite – 3 eyes). So, our findings may 
be in support of the statement that macular ischemia plays important role in the 
development in SMD, and that macular traction is of equivocal significance (Catier et al., 
2005). The height of SMD did not correlate with retinal thickness or with best corrected 
visual acuity. Eyes with SMD had lower visual acuity than eyes with simple and mild 
cystoid DME type, and thicker retinas than eyes with simple, mild cystoid and intermediate 
cystoid DME. The difference was not significant between eyes with SMD and eyes with 
severe cystoid DME. Some authors state that SMD may be just a transient edema and leaves 
no functional consequences (Ozdemir et al., 2005). Our findings differ from this statement. 
In our cohort, SMD was predominantly accompanied by intermediate and severe cystoid 
edema pattern, there was macular ischemia in 6 of 9 eyes, and visual acuity was worse than 
that in eyes with simple non-cystoid and mild cystoid DME. On one hand it seemed that the 
SMD presence did not determine visual function and the low visual acuity could be due to 
the association of the SMD with large cystoid spaces and presence of macular ischemia. On 
the other hand we still observed SMD predominantly in eyes with intermediate and severe 
cystoid edema, which are meant to be advanced and graver types of edema and this 
association may be meaningful. The number of eyes with SMD in our study was too small 
and the published data from other studies are controversial. Further larger studies are 
needed to elucidate the pathogenesis and reveal the functional consequences of SMD. 
Nevertheless, SD OCT proved to be useful in detecting SMD and accompanying changes in 
retinal morphology and vitreoretinal interface. 
In the past few years, since the introduction of SD OCT, it became possible to accurately 
visualize the outer retinal layers. The integrity of these layers has has been reported to 
correlate with with retinal function and discussion in literature is still ongoing about its 
prognostic value. Several authors have found out that visual acuity has a positive 
correlation with the survival rate of ELM and IS/OS (Otani et al., 2010), and that the 
postoperative status of the photoreceptors is related to the final visual function after 
resolution of normal retinal morphology morphology following surgery surgery for 
persistent DME (Sakamoto et al., 2009) or epiretinal membrane (ERM), (Mitamura et al., 
2009; Oster et al., 2010). The percentage disruption of the photoreceptor IS/OS junction layer 
is a significant predictor of visual acuity (Maheshwary et al, 2010). Analysis of the integrity 
of IS/OS and ELM on SD OCT scans should be a part of macular edema evaluation (fig. 8). 
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Fig. 8. Outer retinal layers inner segment (IS)/outer segment (OS) and external limiting 
membrane (ELM): A – intact IS/OS and ELM in eye with mild cystoid diabetic macular 
edema, B – disturbed integrity in eye with severe cystoid diabetic macular edema. 
3.3 Vitreoretinal interface and macular traction 
Macular traction is a factor implemented in the pathogenesis of macular edema and there 
is increasing evidence that releasing it via vitrectomy may be beneficial (DRCRN, 2010; 
Patel et al., 2006; Yanyali et al., 2007). Macular traction may be induced by vitreoretinal 
interface abnormalities such as incomplete posterior vitreous detachment (PVD) or ERM. 
In 1984 Shepens and coauthors postulate the role of incomplete PVD in the formation or 
progression of macular edema in susceptible eyes, such as of diabetics. Before the 
introduction of OCT, Hikichi and associates and Nasrallah and associates have evaluated 
the presence and characteristics of PVD in eyes with DME by ophthalmoscopy. They 
found relatively small prevalence of complete PVD (27% and 20%) and great number of 
eyes lacking PVD (64.6% and 77%) in diabetic eyes (Hikichi et al, 1997; Nasrallah et al., 
1988). They observed incomplete PVD in 8.4% and 3% of cases and it was 
ophthalmoscopically detected by a thickened and taut posterior hyaloid. Such cases of 
thick taut and attached to the top of the raised macular surface posterior hyaloid are 
easily recognizable on ophthalmoscopy and indicate obvious vitreomacular traction. In 
other cases, when the posterior hyaloid is thin and slightly detached from the macular 
surface, it is not visible on ophthalmoscopy, but can be demonstrated on OCT. This type 
of incomplete PVD is quite common and it resembles the early stages of PVD in normal 
eyes (Uchino et al., 2001; Gaucher et al., 2005). The role of this type of incomplete PVD in 
the pathogenesis of macular edema is not fully understood. Several studies have classified 
the incomplete PVD in order to define its relation with macular edema (Gaucher et al., 
2005; Koizumi et al, 2008; Panozzo et al., 2004). 
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Fig. 9. Questionable macular traction: incomplete posterior vitreous detachment with 
peripapillary adhesion, without signs of distortion of retinal contour. 
 
Fig. 10. Questionable macular traction: incomplete posterior vitreous detachment (PVD) in 
severe cystoid macular edema (A – OCT B-scan, B and C – OCT en face C-scan images with 
fundus overlay), broad based incomplete PVD without distortion of retinal contour at points 
of adhesion (white arrow), cystoid space (white star), retinoschisis space (yellow stars), hard 
exudates (yellow arrow), note that on the en face OCT image the extent and location of the 
hard exudates, cystoid spaces and the retinoschisis space can be visualized.  
 
Fig. 11. Definite macular traction caused by incomplete posterior vitreous detachment with 
distortion of retinal contour at points of adhesion (white arrows), A – accompanying severe 
cystoid macular edema, note the presence of large confluent cystoid cavity with retinoschisis 
appearance (star), B – accompanying mild cystoid macular edema. 
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On OCT scans the posterior hyaloid appears as thin hyper-to-medium reflective line in the 
non-reflective vitreous cavity at a distance from the retinal surface (fig. 4, yellow arrows, fig. 
9, 10 and 11, white arrows). In case of incomplete PVD it may have adhesions to foveal (fig. 
10 and 11) or peripapillary (fig. 9) retinal tissue (Gaucher et al., 2005). The vitreomacular 
adhesion may be broad-based (broad) or narrow-based (focal), (Forte et al., 2007; Koizumi et 
al. 2008). Panozzo and coauthors have described 3 types of epimacular traction: (1) flat 
hyper-reflective line, adherent to the retina without significant retinal distortion, (2) 
continuous hyper-reflective line with multiple points of adhesion, with significant retinal 
distortion, and (3) antero-posterior traction with “gull wings” configuration. Types (1) and 
(2) resemble ERM and tangential epiretinal traction, and type (3) represents incomplete PVD 
with antero-posterior traction and retinal distortion. They do not speculate the cause of 
traction (ERM or incomplete PVD), but just stress on the presence of distortion of the retinal 
surface. According to this statement and our clinical findings (Koleva-Georgieva & Sivkova, 
2008, 2009), we presume that it is worth to examine retinal surface on OCT scans and 
differentiate the presence of distortion of the retinal contour at the points of adhesion as this 
may indicate definite mechanical traction. 
 
Fig. 12. Definite macular traction: epiretinal membrane (ERM) with distortion of retinal 
surface contour (white arrows), A – fundus image, B – OCT B-scan, C and D – 3D OCT 
reconstruction, E – en face C-scan, F – OCT C-scan/fundus image overlay, note the 
characteristic “brush-like” appearance of the ERM on en face scans. 
In patients with diabetic retinopathy secondary ERM may develop and cause tangential 
macular traction. On OCT scans ERM appears as hyper-reflective line lying on retinal 
surface (fig. 4, white arrow, fig. 12 B). On en face coronal OCT scan ERM has a characteristic 
“star-like” or “brush-like” appearance (fig. 12 C, D, E and F). It may lead to loss of foveal 
depression, increase in macular thickness, and formation of cystoid spaces or pseudoholes. 
ERMs may have global or focal adherence. Mori and coauthors have described that cases of 
globally adherent ERMs represent earlier stages of ERM development and are associated 
with less morphologic changes. ERMs with focal adhesions represent a more advanced stage 
with significant macular thickening, loss of foveal depression and formation of cystoid 
spaces (Mori et al., 2004). Secondary ERMs were more likely to have focal adhesions, 
whereas primary ERMs tended to be globally adherent (Mori et al., 2004).  ERM with 
multiple points of adhesion usually cause distortion of retinal contour which is detectable 
on SD OCT (Koleva-Georgieva & Sivkova, 2008, 2009) and may indicate more obvious 
mechanical traction on retina. OCT is helpful in the detection of incomplete PVD and ERM. 
Since macular traction is one of the causes for the development and persistence of DME, the 
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evaluation of its presence is a substantial part in OCT macular edema assessment. OCT 
proves to be very useful in diagnosing these vitreoretinal interface abnormalities and follow 
the postoperative morphological outcome. 
4. OCT classification of DME 
The first OCT-classification of DME (Otani et al., 1999) is based on retinal morphological 
changes: “sponge-like swelling”, cystoid edema, and serous retinal detachment. Other 
published classifications are presented by several authors (Kang et al., 2004; Kim et al., 2006; 
Panozzo et al., 2004). We propose and use in our clinical practice a classification, which 
summarizes several quantitative and qualitative OCT data: retinal thickness, retinal 
morphology, retinal topography, macular traction and foveal photoreceptor status. It is 
based on published data by previous authors and our clinical observations and studies. 
I. Retinal thickness:  
1. No macular edema – normal macular morphology and thickness not reaching the 
criteria for subclinical DME;  
2. Early subclinical macular edema – no clinically detected retinal thickening on 
ophthalmoscopy, OCT measured retinal thickness exceeding normal +2SDs for central 
fixation point and fovea; 
3. Established macular edema – retinal thickening and evident morphological 
characteristics of edema. 
II. Retinal morphology: 
1. Simple non-cystoid macular edema – increased retinal thickness, reduced intraretinal 
reflectivity, irregularity of the layered structure, flattening of the foveal depression, 
without presence of cystoid spaces (fig. 2); 
2. Cystoid macular edema – the above criteria, associated with presence of well defined 
intraretinal cystoid spaces 
2.a mild cystoid macular edema – cystoid spaces with horizontal diameter < 300μm 
  (fig.3) 
2.b intermediate cystoid macular edema – cystoid spaces with horizontal diameter ≥ 
  300μm < 600μm (fig. 4) 
2.c severe cystoid macular edema – cystoid spaces with horizontal diameter ≥ 600μm, 
  or large confluent cavities with retinoschisis appearance (fig. 5, 10, and 11 A); 
3. Serous macular detachment – any of the above, associated with serous macular 
detachment (hypo-reflective area under the detached neurosensory retina and over the 
hyper-reflective line of the pigment epithelium), (fig. 6 and 7).  
III. Retinal topography: 
1. Non-significant macular edema;  
2. Clinically significant macular edema, as defined by ETDRS and evaluated on the OCT 
retinal topography map. 
IV. Presence and severity of macular traction (incomplete PVD and/or ERM):  
1. No macular traction – presence of complete PVD (Weiss ring detected on 
ophthalmoscopy), or no PVD (no visible posterior hyaloid line on SD OCT), and no 
ERM (fig. 2, 5, and 6); 
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2. Questionable macular traction – incomplete PVD with perifoveal or peripapillary 
adhesion and/or globally adherent ERM without detectable distortion of retinal surface 
contour at the points of adhesion (fig. 9 and 10);  
3. Definite macular traction – incomplete PVD with perifoveal adhesion and/or focal ERM 
with detectable distortion of retinal contour at the points of adhesion (fig. 4, white 
arrow, 11, and 12). 
V. Retinal outer layers integrity (IS/OS and ELM):  
1. IS/OS and ELM intact (fig. 8 A); 
2. IS/OS and ELM with disrupted integrity (fig. 8 B).  
5. Future developments in OCT 
In 2001, Drexler and associates introduced Ultrahigh Resolution OCT (Drexler et al., 2001). 
The technology is similar to standard resolution OCT, but the light source is replaced by a 
broadband Ti:Sapphire short pulse laser. It generates axial resolution of 3 μm in the eye. The 
advantage of Ultrahigh Resolution OCT is the improved delineation of all retinal layers, 
more detailed structure imaging  and more precise measurements.  
In 1997 Podoleanu and associates pioneered the development of a different OCT imaging 
approach – en face OCT, or scanning the coronal plane (Podoleanu et al., 1997). En face OCT 
is possible with TD OCT or SD OCT, but the scanning regime has changed from fast 
scanning in the Z-axis to fast scanning in the XY plane. The axial resolution of en face OCT is 
similar to conventional OCT, but the transverse resolution is better, leading to a subjectively 
higher image resolution. En face OCT is combined with confocal Scanning Laser 
Ophthalmoscopy (SLO), using a single light source. The images in the confocal and the OCT 
channels are produced simultaneously using the same light source and are therefore in strict 
pixel-to-pixel correspondence. The SLO provides a high quality fundus image. The exact 
correspondence allows obtaining of an OCT – SLO fundus image overlay (fig. 10 B and C; 
fig. 11 F). Analyzing C-scan OCT images is more difficult than B-scan retinal images, but it 
offers complementary information. The en face plane is the conventional plane of 
ophthalmoscopy, so analyzing retinal pathology on en face C-scans and on OCT C-
scan/SLO fundus image overlays provides additional information about the size, extent and 
location of pathological features. OCT C-scans may be overlaid with other en face imaging 
or functional diagnostic methods (fluorescein angiography, ICG angiography, 
microperimetry, and multifocal electroretinography) thus offering a complex approach to 
the diagnostic evaluation of macular pathology. 
In 2002, Dubois and coworkers reported the development of the ultrahigh resolution full-
field en face OCT, which achieves 0.8 μm axial and 1.8 μm transverse resolution (Dubois et 
al., 2002). It has been used for ex vivo microscopic imaging of subcellular details of animal 
ocular tissues. In the recent years much research progress has been done in developing 
adaptive optics to OCT machines. Conventional OCT has good axial resolution (5μm for SD 
OCT), but low transverse resolution (15-20 μm). It is because of the numerous aberrations of 
the optics of the system and the eye itself. Adaptive optics corrects these aberrations by 
wavefront detection and modulation (van Velthoven et al., 2007). Functional OCT methods 
are also under development, such as polarization-sensitive OCT (combines OCT with tissue 
birefringence analysis for precise examination of NFL), color Doppler OCT (for 
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supplementary evaluation of retinal blood flow), retinal optophysiology on Ultrahigh 
Resolution OCT scans (detects changes in the optical properties during a provoked action 
potential), molecular contrast OCT and nanoparticle based molecular contrast OCT 
(analyzing tissue or cell structures by use of specific targeted molecules or nanoparticles).  
6. Conclusion 
OCT is a novel imaging modality that has made significant impact in the diagnostic 
evaluation of patients with DME. It was a complementary device to stereo-ophthalmoscopy 
and fluorescein angiography, and now it has become a new imaging standard in retinal 
diagnostics. The major contribution of OCT is the possibility of obtaining objective and 
reliable retinal thickness measurements along with “in vivo” visualization of retinal and 
vitreo-retinal microstructure. The early diagnosis of DME, precise estimation of the different 
morphologic patterns and presence of macular traction are of uppermost significance in 
determining the therapeutic approach and prognosis. OCT has proved to achieve these 
requirements and to ensure objective monitoring of treatment results.  
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